Quick answer: GLP-1 and medical weight loss is the fastest-growing patient acquisition category in healthcare, and also the most competitive and most restricted. The practices that win aren't the ones with the biggest ad budgets — they're the ones that compete on clinical depth and the patient relationship rather than trying to out-spend the DTC giants, that handle the strict advertising compliance (LegitScript, platform restrictions) correctly, and that build for retention because the economics live in the subscription, not the first fill. This guide covers how independent practices actually win GLP-1 patients against Ro and Hims, what compliance requires, and how to measure a program that pays back over months, not on day one.
Every practice wants a GLP-1 program right now, and for good reason: the demand is enormous. But it's also where acquisition costs are climbing fastest, where national DTC brands are spending aggressively, and where the ad platforms are strictest. Winning here requires a different playbook than any other category.
The hard truth: you can't out-spend the DTC giants
Ro, Hims, and the national telehealth brands are spending at a scale no independent practice can match. If your plan is to win the same auction on the same broad keywords, you'll lose. The good news is you don't have to play that game, because you have something they can't offer.
DTC weight-loss brands sell convenience and a subscription. What they can't sell is a real clinical relationship, local trust, continuity of care, and a provider who actually knows the patient. A meaningful share of patients — especially those with complex health situations or who've been burned by the "cattle-call" telehealth experience — want exactly that. Your marketing should lean into it: position your program as medically grounded, relationship-driven, and thorough, not a prescription vending machine. That's a message the giants structurally cannot copy, and it's how independent practices win the patients worth having.
Compliance is not optional
GLP-1 and weight-loss marketing is among the most restricted advertising categories that exists. Google and Meta both limit weight-loss and prescription-medication advertising, and many programs need LegitScript certification before they can run ads at all. An agency or in-house team that hand-waves this will get your ads disapproved, your account flagged, or worse.
Build the compliance foundation first: understand the platform rules for your specific offering, get LegitScript certification if your model requires it, and structure campaigns and landing pages to stay inside the guidelines. This is unglamorous, but it's the difference between a program that runs and one that gets shut off the week you launch.
Retention is where the money is
The single most important number in GLP-1 marketing isn't cost per lead. It's whether patients stay. A patient who fills once and disappears rarely pays back the acquisition cost. A patient who stays in a program for months, supported and adherent, is where the economics work.
That changes how you market. The best GLP-1 programs treat retention — follow-up, adherence support, the ongoing relationship — as part of the acquisition system, not an afterthought. Your content, your intake, and your patient experience should all be built to attract patients who want a sustained program, not a one-time script. Marketing that optimizes for the cheapest first fill attracts exactly the patients who churn.
What to build
A program story, not a product page. Explain your clinical approach, what makes your program different from the DTC experience, and what a patient's journey looks like. This is your differentiation and your compliance-safe messaging in one.
Education content that builds trust. Patients researching GLP-1s have real questions and real fears — side effects, cost, what happens when they stop, whether it's safe. Honest, structured answers build the trust that converts, and get you cited when patients ask AI the same questions.
Direct-answer FAQ content. "How much does a GLP-1 program cost," "is medical weight loss covered by insurance," "what's the difference between a clinic and Hims" — the questions patients actually ask, answered plainly.
Local and relationship positioning. For practices with a physical location, local trust is a genuine advantage over national DTC. Lean into it.
How AI search is reshaping GLP-1 discovery
Patients increasingly start their GLP-1 research by asking AI: "is a GLP-1 program worth it," "GLP-1 clinic near me," "how to get semaglutide safely." The AI answer shapes which options they consider. Practices that publish credible, structured, relationship-forward content can get recommended in those answers — and for an independent practice, being surfaced by AI as the trustworthy, medically-grounded alternative to the DTC giants is a genuinely winnable position, because that's the story the giants can't tell about themselves.
How to measure it
Track cost per enrolled, retained patient against program lifetime value, not cost per lead. Because it's a subscription/recurring model, first-visit ROAS badly understates the true value of a patient who stays. Measure enrollment and retention, and you'll make the right spending decisions. Optimize to cheap leads, and you'll scale churn.
Frequently asked questions
How do independent practices compete with Ro and Hims for GLP-1 patients?
Not on spend — you'll lose that race. You compete on what they can't offer: real clinical depth, continuity of care, local trust, and a genuine provider relationship. Position your program as medically grounded and relationship-driven, and you attract the patients who want more than a subscription.
Do GLP-1 ads require special compliance?
Yes. Weight-loss and prescription-medication advertising is heavily restricted on Google and Meta, and many programs require LegitScript certification before running ads. Building around these rules from the start is essential — ignoring them gets ads disapproved and accounts flagged.
Why does retention matter so much in GLP-1 marketing?
The economics depend on it. A patient who fills once and leaves rarely covers the acquisition cost. Programs that treat retention as part of the system — follow-up, adherence support, the ongoing relationship — are the ones that are actually profitable.
How much does it cost to acquire a GLP-1 patient?
Acquisition costs are rising as competition intensifies. The meaningful number is cost per enrolled, retained patient relative to program lifetime value, not cost per lead — a subscription model can support a higher acquisition cost if patients stay.
How do I get my weight-loss program to show up in AI search?
Publish credible, structured, relationship-forward content: your clinical approach, honest education, and direct-answer FAQs. For an independent practice, AI is a real opportunity to be positioned as the trustworthy, medically-grounded alternative to national DTC brands — a story they can't tell about themselves.
Mike Funkhouser is the founder of Practice Growth Co, a healthcare marketing agency focused on patient acquisition for specialty medical practices, and a contributor to Medical Economics on AI search and patient acquisition. [Book a strategy call](/book-a-strategy-call).